Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, antihypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives. The company was founded in 1987 and is headquartered in Mumbai, India.
Stock data | 2024 | Change |
---|---|---|
Price | $8.70 | N/A |
Market Cap | $699.97M | N/A |
Shares Outstanding | 80.48M | N/A |
Employees | 392.00 | N/A |